Targeting the spliceosome.
Rymond
Brian
B
D000970:Antineoplastic Agents / Q000737:chemistry*; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D017413:Ribonucleoprotein, U2 Small Nuclear / Q000037:antagonists & inhibitors; D017381:Spliceosomes / Q000187:drug effects*
D000970:Antineoplastic Agents; D017413:Ribonucleoprotein, U2 Small Nuclear